Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 703705, 14 pages
http://dx.doi.org/10.1155/2013/703705
Research Article

Gene Expression Profiling on the Molecular Action of Danshen-Gegen Formula in a Randomized Placebo-Controlled Trial of Postmenopausal Women with Hypercholesterolemia

1Institute of Chinese Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong
2State Key Laboratory of Phytochemistry & Plant Resources in West China, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong
3School of Biomedical Sciences, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong
4Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong
5The Chinese University of Hong Kong-Zhejiang University Joint Laboratory on Natural Products and Toxicology Research, Shatin, New Territories, Hong Kong

Received 22 March 2013; Revised 28 May 2013; Accepted 16 June 2013

Academic Editor: Myeong S. Lee

Copyright © 2013 Chi-Man Koon et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. M. C. Rosano, C. Vitale, G. Marazzi, and M. Volterrani, “Menopause and cardiovascular disease: the evidence,” Climacteric, vol. 10, supplement 1, pp. 19–24, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Rozenberg, J. Vandromme, and C. Antoine, “Postmenopausal hormone therapy: risks and benefits,” Nature Reviews Endocrinology, vol. 9, no. 4, pp. 216–227, 2013. View at Publisher · View at Google Scholar
  3. D. W. Cheung, C. M. Koon, E. Wat et al., “A herbal formula containing roots of Salvia miltiorrhiza (Danshen) and Pueraria lobata (Gegen) inhibits inflammatory mediators in LPS-stimulated RAW 264.7 macrophages through inhibition of nuclear factor κB (NF κB) pathway,” Journal of Ethnopharmacology, vol. 145, no. 3, pp. 776–783, 2013. View at Publisher · View at Google Scholar
  4. Y. Deng, E. S. K. Ng, J. H. K. Yeung et al., “Mechanisms of the cerebral vasodilator actions of isoflavonoids of Gegen on rat isolated basilar artery,” Journal of Ethnopharmacology, vol. 139, no. 1, pp. 294–304, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. F. F. Y. Lam, S. Y. Deng, E. S. K. Ng et al., “Mechanisms of the relaxant effect of a Danshen and Gegen formulation on rat isolated cerebral basilar artery,” Journal of Ethnopharmacology, vol. 132, no. 1, pp. 186–192, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. C. F. Ng, C. M. Koon, D. W. S. Cheung et al., “The anti-hypertensive effect of Danshen (Salvia miltiorrhiza) and Gegen (Pueraria lobata) formula in rats and its underlying mechanisms of vasorelaxation,” Journal of Ethnopharmacology, vol. 137, no. 3, pp. 1366–1372, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. C. M. Koon, K. S. Woo, P. C. Leung, and K. P. Fung, “Salviae miltiorrhizae Radix and Puerariae lobatae Radix herbal formula mediates anti-atherosclerosis by modulating key atherogenic events both in vascular smooth muscle cells and endothelial cells,” Journal of Ethnopharmacology, vol. 138, no. 1, pp. 175–183, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Wing-Shing Cheung, C. M. Koon, C. F. Ng et al., “The roots of Salvia miltiorrhiza (Danshen) and Pueraria lobata (Gegen) inhibit atherogenic events: a study of the combination effects of the 2-herb formula,” Journal of Ethnopharmacology, vol. 143, no. 3, pp. 859–866, 2012. View at Publisher · View at Google Scholar
  9. F. Hu, C. M. Koon, J. Y. Chan, K. M. Lau, Y. W. Kwan, and K. P. Fung, “Involvements of calcium channel and potassium channel in Danshen and Gegen decoction induced vasodilation in porcine coronary LAD artery,” Phytomedicine, vol. 19, no. 12, pp. 1051–1058, 2012. View at Publisher · View at Google Scholar
  10. F. Hu, C. M. Koon, J. Y. Chan, K. M. Lau, and K. P. Fung, “The cardioprotective effect of Danshen and Gegen decoction on rat hearts and cardiomyocytes with post-ischemia reperfusion injury,” BMC Complementary and Alternative Medicine, vol. 10,, no. 12, p. 249, 2012. View at Publisher · View at Google Scholar
  11. C. C. Fong, F. Wei, Y. Chen et al., “Danshen-Gegen decoction exerts proliferative effect on rat cardiac myoblasts H9c2 via MAPK and insulin pathways,” Journal of Ethnopharmacology, vol. 138, no. 1, pp. 60–66, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. W. Y. Tam, P. Chook, M. Qiao et al., “The efficacy and tolerability of adjunctive alternative herbal medicine (Salvia miltiorrhiza and Pueraria lobata) on vascular function and structure in coronary patients,” Journal of Alternative and Complementary Medicine, vol. 15, no. 4, pp. 415–421, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Censi, G. Calcagnini, P. Bartolini, and A. Giuliani, “Principal component analysis of gene expression data: the case of atrial fibrillation,” in Proceedings of the 3rd International Symposium on Applied Sciences in Biomedical and Communication Technologies (ISABEL '10), pp. 1–4, IEEE, Roma, Italy, November 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Rossi, T. Grimaldi, G. Origliani, G. Fantini, F. Coppi, and M. G. Modena, “Menopause and cardiovascular risk,” Pathophysiology of Haemostasis and Thrombosis, vol. 32, no. 5-6, pp. 325–328, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Beghetti, S. M. Black, and J. R. Fineman, “Endothelin-1 in congenital heart disease,” Pediatric Research, vol. 57, no. 5, pp. 16R–20R, 2005. View at Google Scholar
  16. G. P. Diller and M. A. Gatzoulis, “Pulmonary vascular disease in adults with congenital heart disease,” Circulation, vol. 115, no. 8, pp. 1039–1050, 2007. View at Google Scholar
  17. S. J. Wort, M. Woods, T. D. Warner, T. W. Evans, and J. A. Mitchell, “Endogenously released endothelin-1 from human pulmonary artery smooth muscle promotes cellular proliferation: relevance to pathogenesis of pulmonary hypertension and vascular remodeling,” American Journal of Respiratory Cell and Molecular Biology, vol. 25, no. 1, pp. 104–110, 2001. View at Google Scholar
  18. Y. Hirata, Y. Takagi, Y. Fukuda, and F. Marumo, “Endothelin is a potent mitogen for rat vascular smooth muscle cells,” Atherosclerosis, vol. 78, no. 2-3, pp. 225–228, 1989. View at Google Scholar
  19. D. D. Rees, R. M. Palmer, and S. Moncada, “Role of endothelium-derived nitric oxide in the regulation of blood pressure,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 9, pp. 3375–3378, 1989. View at Google Scholar
  20. C. X. Zhao, X. Xu, Y. Cui et al., “Increased endothelial nitric-oxide synthase expression reduces hypertension and hyperinsulinemia in fructose-treated rats,” Journal of Pharmacology and Experimental Therapeutics, vol. 328, no. 2, pp. 610–620, 2009. View at Publisher · View at Google Scholar
  21. S. Moncada, R. M. Palmer, and E. A. Higgs, “Nitric oxide: physiology, pathophysiology, and pharmacology,” Pharmacological Reviews, vol. 43, no. 2, pp. 109–142, 1991. View at Google Scholar
  22. C. Nathan and Q. W. Xie, “Nitric oxide synthases: roles, tolls, and controls,” Cell, vol. 78, no. 6, pp. 915–918, 1994. View at Google Scholar
  23. S. Janssens, D. Flaherty, Z. Nong et al., “Human endothelial nitric oxide synthase gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation after balloon injury in rats,” Circulation, vol. 97, no. 13, pp. 1274–1281, 1998. View at Google Scholar · View at Scopus
  24. F. Sharif, S. O. Hynes, K. J. A. McCullagh et al., “Gene-eluting stents: non-viral, liposome-based gene delivery of eNOS to the blood vessel wall in vivo results in enhanced endothelialization but does not reduce restenosis in a hypercholesterolemic model,” Gene Therapy, vol. 19, no. 3, pp. 321–328, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Funalot, D. Courbon, T. Brousseau et al., “Genes encoding endothelin-converting enzyme-1 and endothelin-1 interact to influence blood pressure in women: the EVA study,” Journal of Hypertension, vol. 22, no. 4, pp. 739–743, 2004. View at Google Scholar
  26. A. Aperia, B. Sahlgren, A. C. Eklöf, S. Lundin, and P. Melin, “Role of arginine-vasopressin for the development of hypertension following aortic constriction,” Acta Physiologica Scandinavica, vol. 128, no. 4, pp. 495–499, 1986. View at Google Scholar
  27. F. Cambien, O. Poirier, L. Lecerf et al., “Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction,” Nature, vol. 359, no. 6396, pp. 641–644, 1992. View at Publisher · View at Google Scholar · View at Scopus
  28. Z. Yang, D. R. Sibley, and P. A. Jose, “D5 dopamine receptor knockout mice and hypertension,” Journal of Receptors and Signal Transduction, vol. 24, no. 3, pp. 149–164, 2004. View at Google Scholar
  29. C. Zeng, Z. Yang, L. D. Asico, and P. A. Jose, “Regulation of blood pressure by D5 dopamine receptors,” Cardiovascular & Hematological Agents in Medicinal Chemistry, vol. 5, no. 3, pp. 241–248, 2007. View at Google Scholar
  30. C. Zeng, G. M. Eisner, R. A. Felder, and P. A. Jose, “Dopamine receptor and hypertension,” Current Medicinal Chemistry, vol. 3, no. 1, pp. 69–77, 2005. View at Google Scholar
  31. C. H. Lee, J. W. Roh, J. S. Choi et al., “Cyclooxygenase-2 is an independent predictor of poor prognosis in uterine leiomyosarcomas,” International Journal of Gynecological Cancer, vol. 21, no. 4, pp. 668–672, 2011. View at Publisher · View at Google Scholar
  32. C. L. Jackson and S. M. Schwartz, “Pharmacology of smooth muscle cell replication,” Hypertension, vol. 20, no. 6, pp. 713–736, 1992. View at Google Scholar
  33. A. W. Clowes, M. M. Clowes, and M. A. Reidy, “Kinetics of cellular proliferation after arterial injury. III. Endothelial and smooth muscle growth in chronically denuded vessels,” Laboratory Investigation, vol. 54, no. 3, pp. 295–303, 1986. View at Google Scholar
  34. B. Ho, G. Hou, J. G. Pickering, G. Hannigan, B. L. Langille, and M. P. Bendeck, “Integrin-linked kinase in the vascular smooth muscle cell response to injury,” American Journal of Pathology, vol. 173, no. 1, pp. 278–288, 2008. View at Publisher · View at Google Scholar
  35. S. H. Zaidi, X. M. You, S. Ciura, S. O’Blenes, M. Husain, and M. Rabinovitch, “Suppressed smooth muscle proliferation and inflammatory cell invasion after arterial injury in elafin-overexpressing mice,” The Journal of Clinical Investigation, vol. 105, no. 12, pp. 1687–1695, 2000. View at Google Scholar
  36. X. Guo, K. H. Chen, Y. Guo, H. Liao, J. Tang, and R. P. Xiao, “Mitofusin 2 triggers vascular smooth muscle cell apoptosis via mitochondrial death pathway,” Circulation Research, vol. 101, no. 11, pp. 1113–1122, 2007. View at Google Scholar
  37. M. Iglarz and E. L. Schiffrin, “Role of endothelin-1 in hypertension,” Current Hypertension Reports, vol. 5, no. 2, pp. 144–148, 2003. View at Google Scholar
  38. Y. Miyamoto, Y. Saito, N. Kajiyama et al., “Endothelial nitric oxide synthase gene is positively associated with essential hypertension,” Hypertension, vol. 32, no. 1, pp. 3–8, 1998. View at Google Scholar · View at Scopus
  39. K. Hasegawa, H. Fujiwara, K. Doyama et al., “Endothelin-1-selective receptor in the arterial intima of patients with hypertension,” Hypertension, vol. 23, no. 3, pp. 288–293, 1994. View at Google Scholar